Last 48 quarters of trend data · Healthcare · Medical Devices
Quarterly valuation ratios — annualised for comparability. YoY Δ shows same-quarter-prior-year change.
| Metric | TTM | Q3 '26 | Q2 '26 | Q1 '26 | Q4 '25 | Q3 '25 | Q2 '25 | Q1 '25 | Q4 '24 | Q3 '24 | Q2 '24 | Q1 '24 | Q4 '23 | Q3 '23 | Q2 '23 | Q1 '23 | Q4 '22 | Q3 '22 | Q2 '22 | Q1 '22 | Q4 '21 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| P/E Ratio → | -55.65 | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | |
| P/S Ratio | 1.79 | 2.08 | 2.55 | 1.65 | 1.71 | 1.45 | 1.29 | 1.50 | 1.40 | 1.75 | 1.81 | 2.24 | 2.09 | 1.84 | 2.86 | 4.27 | 3.68 | 4.03 | 5.71 | 6.40 | 7.39 |
| — | +43.7% | +98.2% | +9.5% | +22.5% | -17.4% | -28.8% | -33.0% | -33.2% | -4.9% | -36.8% | -47.5% | -43.1% | -54.3% | -49.9% | -33.2% | -50.2% | -44.4% | -29.0% | -41.1% | -28.0% | |
| P/B Ratio | 5.93 | 6.28 | 8.28 | 5.17 | 6.09 | 4.90 | 4.80 | 4.62 | 5.00 | 5.94 | 6.47 | 6.86 | 7.32 | 5.98 | 8.60 | 8.89 | 9.45 | 8.61 | 12.19 | 11.91 | 13.77 |
| — | +28.2% | +72.5% | +11.9% | +21.9% | -17.5% | -25.8% | -32.6% | -31.8% | -0.6% | -24.7% | -22.8% | -22.5% | -30.6% | -29.5% | -25.4% | -31.4% | -33.3% | +1.5% | +8.8% | +23.4% | |
| P/FCF | 819.32 | 49.64 | — | — | 20.22 | 811.20 | — | — | 17.98 | 24.08 | 226.09 | 100.04 | — | — | — | — | — | — | — | — | — |
| — | -93.9% | — | — | +12.5% | +3268.1% | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | |
| EV / EBITDA | — | — | — | 1136.68 | — | 59.88 | — | — | — | — | — | — | 72.91 | — | — | — | — | — | — | — | — |
| — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | |
| EV / EBIT | — | — | — | 335.59 | — | 44.36 | — | — | — | — | — | — | 129.75 | — | — | — | — | — | — | — | — |
| — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
Quarterly margins and returns. Watch for margin compression across consecutive quarters.
| Metric | TTM | Q3 '26 | Q2 '26 | Q1 '26 | Q4 '25 | Q3 '25 | Q2 '25 | Q1 '25 | Q4 '24 | Q3 '24 | Q2 '24 | Q1 '24 | Q4 '23 | Q3 '23 | Q2 '23 | Q1 '23 | Q4 '22 | Q3 '22 | Q2 '22 | Q1 '22 | Q4 '21 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Gross Margin | 54.5% | 52.4% | 51.4% | 52.0% | 51.5% | 53.4% | 55.2% | 58.8% | 53.9% | 56.9% | 54.7% | 55.4% | 55.5% | 54.9% | 54.9% | 55.8% | 55.7% | 55.4% | 51.9% | 51.7% | 51.1% |
| — | -1.8% | -6.9% | -11.6% | -4.4% | -6.2% | +1.0% | +6.0% | -2.9% | +3.8% | -0.4% | -0.7% | -0.4% | -0.9% | +5.8% | +7.9% | +8.9% | +7.8% | +1.1% | -1.6% | -10.0% | |
| Operating Margin | -4.2% | -10.3% | -3.2% | -0.7% | -1.1% | 2.3% | -6.5% | -13.5% | -2.9% | -2.1% | -8.5% | -20.8% | 2.1% | -13.2% | -30.0% | -45.7% | -22.6% | -18.8% | -16.7% | -26.3% | -17.5% |
| — | -537.4% | +50.4% | +95.1% | +61.1% | +212.3% | +23.3% | +34.9% | -236.7% | +84.2% | +71.6% | +54.5% | +109.2% | +30.0% | -79.7% | -73.6% | -29.4% | +38.9% | +63.6% | +62.6% | +65.7% | |
| Net Margin | -7.6% | -1.0% | -5.1% | -3.1% | -3.8% | -0.0% | -10.9% | -17.8% | -5.0% | -6.4% | -12.8% | -25.3% | -2.8% | -18.3% | -34.2% | -50.4% | -30.9% | -21.4% | -20.5% | -32.8% | -22.9% |
| — | -2539.9% | +53.0% | +82.9% | +23.8% | +99.4% | +15.1% | +29.3% | -74.7% | +65.1% | +62.5% | +49.9% | +90.8% | +14.8% | -67.0% | -53.7% | -35.3% | +37.7% | +58.1% | +56.1% | +55.1% |
| Metric | TTM | Q3 '26 | Q2 '26 | Q1 '26 | Q4 '25 | Q3 '25 | Q2 '25 | Q1 '25 | Q4 '24 | Q3 '24 | Q2 '24 | Q1 '24 | Q4 '23 | Q3 '23 | Q2 '23 | Q1 '23 | Q4 '22 | Q3 '22 | Q2 '22 | Q1 '22 | Q4 '21 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| ROE | -25.6% | -0.7% | -4.2% | -2.5% | -3.4% | -0.0% | -10.2% | -13.6% | -4.5% | -5.6% | -11.5% | -18.7% | -2.6% | -14.4% | -23.9% | -24.4% | -19.1% | -11.2% | -10.7% | -14.8% | -10.9% |
| — | -2229.9% | +58.3% | +82.0% | +24.3% | +99.4% | +11.7% | +27.1% | -75.0% | +61.1% | +51.8% | +23.3% | +86.4% | -28.3% | -123.6% | -64.8% | -74.6% | +25.3% | +38.5% | +16.7% | +19.0% | |
| ROA | -7.4% | -0.3% | -1.4% | -0.7% | -1.0% | -0.0% | -2.7% | -3.8% | -1.3% | -1.6% | -3.1% | -5.0% | -0.7% | -3.6% | -6.5% | -7.3% | -6.3% | -3.9% | -3.8% | -5.3% | -4.0% |
| — | -2914.6% | +49.5% | +80.5% | +22.6% | +99.4% | +11.8% | +24.4% | -96.2% | +56.4% | +52.6% | +31.5% | +89.5% | +8.6% | -69.9% | -36.7% | -57.3% | +30.2% | +44.7% | +32.3% | +39.6% | |
| ROIC | -4.7% | -3.4% | -1.0% | -0.2% | -0.3% | 0.7% | -1.9% | -3.2% | -0.8% | -0.5% | -2.2% | -4.5% | 0.6% | -3.2% | -7.2% | -8.8% | -5.9% | -4.2% | -3.9% | -5.8% | -5.0% |
| — | -614.0% | +44.1% | +94.1% | +59.1% | +221.1% | +13.5% | +28.1% | -246.5% | +83.2% | +70.2% | +48.6% | +109.5% | +24.0% | -85.9% | -51.3% | -18.4% | +51.5% | +59.4% | +40.9% | +35.5% |
Quarterly solvency trend — watch for debt spikes or covenant pressure.
| Metric | TTM | Q3 '26 | Q2 '26 | Q1 '26 | Q4 '25 | Q3 '25 | Q2 '25 | Q1 '25 | Q4 '24 | Q3 '24 | Q2 '24 | Q1 '24 | Q4 '23 | Q3 '23 | Q2 '23 | Q1 '23 | Q4 '22 | Q3 '22 | Q2 '22 | Q1 '22 | Q4 '21 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Debt / Equity | 1.49 | 0.98 | 1.09 | 1.43 | 1.49 | 1.58 | 1.76 | 1.77 | 1.72 | 1.80 | 1.96 | 2.01 | 1.75 | 1.94 | 1.70 | 1.51 | 1.27 | 1.18 | 1.15 | 1.10 | 1.02 |
| — | -37.8% | -38.3% | -19.4% | -13.4% | -12.5% | -10.3% | -11.8% | -1.5% | -6.9% | +15.2% | +32.8% | +37.6% | +64.0% | +48.6% | +37.2% | +24.4% | +16.2% | +17.9% | +23.3% | +58.8% | |
| Debt / EBITDA | — | — | — | 1046.86 | — | 60.68 | — | — | — | — | — | — | 57.64 | — | — | — | — | — | — | — | — |
| — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | |
| Current Ratio | 1.73 | 1.96 | 1.83 | 1.63 | 1.73 | 1.89 | 2.00 | 2.32 | 2.39 | 2.59 | 2.51 | 2.41 | 2.14 | 1.88 | 2.01 | 2.09 | 1.45 | 1.73 | 2.08 | 2.59 | 2.38 |
| — | +3.6% | -8.2% | -29.5% | -27.6% | -27.0% | -20.3% | -4.0% | +11.7% | +37.3% | +24.6% | +15.4% | +47.2% | +8.7% | -3.2% | -19.3% | -39.0% | -37.0% | -26.3% | -21.7% | -22.1% | |
| Quick Ratio | 1.17 | 1.15 | 1.07 | 1.06 | 1.17 | 1.29 | 1.35 | 1.63 | 1.79 | 1.92 | 1.83 | 1.72 | 1.55 | 1.35 | 1.47 | 1.62 | 1.21 | 1.44 | 1.73 | 2.16 | 2.04 |
| — | -10.9% | -21.1% | -34.6% | -34.5% | -32.7% | -26.2% | -5.3% | +15.6% | +41.7% | +24.7% | +6.1% | +28.4% | -5.9% | -14.9% | -25.2% | -40.9% | -37.5% | -26.4% | -24.5% | -23.6% | |
| Interest Coverage | -0.83 | -4.79 | -0.68 | 0.17 | -0.05 | 1.03 | -1.62 | -2.62 | -0.19 | -0.26 | -1.50 | -3.30 | 0.41 | -2.05 | -5.07 | -8.66 | -6.87 | -5.01 | -5.17 | -7.85 | -5.78 |
| — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
Includes 30+ ratios · 48 years · Updated daily
Live VCP patterns, Cup & Handle overlays, support/resistance, and AI trade plans.
High-probability breakout stocks crossing their pivot across 5 pattern engines.
DCF models, multiple analysis, and analyst estimates.
10-year return with dividends reinvested.
Compare growth, multiples, and margins vs sector.
Quick answers to the most common questions about buying CERS stock.
Cerus Corporation's current P/E is -55.6x. Quarterly P/E ratios can vary due to seasonal revenue patterns and one-time charges.
Cerus Corporation's current operating margin is -4.2%. Margins have been compressing over recent quarters. Quarterly margins are particularly useful for identifying trend inflections that annual data smooths over.
Quarterly financial ratios reveal short-term trend shifts — margin compression, debt spikes, or valuation re-ratings — that annual figures smooth over. They're essential for active investors tracking Cerus Corporation's business trajectory between earnings reports.